piritrexim has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, H; Cunliffe, WJ; Klaber, MR; Layton, AM; Manna, VK; Perkins, W; Saihan, EM; Tidman, MJ; Vestey, JP; Williams, RE | 1 |
| Benik, K; Guzzo, C; Johnson, J; Lazarus, G; Weinstein, G | 1 |
2 trial(s) available for piritrexim and Psoriasis
| Article | Year |
|---|---|
A multicentre 12-week open study of a lipid-soluble folate antagonist, piritrexim in severe psoriasis.
Topics: Drug Administration Schedule; Female; Folic Acid Antagonists; Humans; Liver; Male; Middle Aged; Psoriasis; Pyrimidines; Severity of Illness Index; Vomiting | 1993 |
Treatment of psoriasis with piritrexim, a lipid-soluble folate antagonist.
Topics: Adult; Aged; Drug Administration Schedule; Female; Folic Acid Antagonists; Humans; Male; Middle Aged; Psoriasis; Pyrimidines | 1991 |